Market revenue in 2023 | USD 0.6 million |
Market revenue in 2030 | USD 1.3 million |
Growth rate | 11.5% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 66.67% in 2023. Horizon Databook has segmented the New Zealand pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the pharmaceutical and biotechnology sectors is expected to improve the demand for sterility testing as these industries need to ensure the safety & efficacy of their products. Health organizations and various multinational companies collaboratively strive to maximize the complete potential of clinical trials.
For instance, in November 2023, Syneos Health entered into a partnership agreement with P3 Research Ltd Network, marking an extension of the company’s clinical trial capabilities across a diverse spectrum of therapeutic areas in the country.
With this collaboration, P3 Research Ltd Network is now integrated into the Syneos Health Catalyst and Site Network Partnerships program, encompassing more than 110 clinical sites and over 60 commercial site networks.
Horizon Databook provides a detailed overview of country-level data and insights on the New Zealand pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into New Zealand pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account